For the Quarter Ending September 2025
North America
• In United States, the Sevelamer Carbonate Price Index rose quarter-over-quarter in Q3 2025, driven by rising costs and tight supply.
• Production costs increased, influenced by a 2.6% PPI in August 2025 and rising Epichlorohydrin feedstock and energy expenses.
• Overall inflation, indicated by a 3.0% CPI in September 2025, contributed to higher operational costs.
• Demand for Sevelamer Carbonate was supported by increased drug approvals and a 4.3% unemployment rate in September 2025.
• Retail sales increased 5.42% in September 2025, indirectly supporting healthcare spending and patient access.
• Tight Epichlorohydrin supply and limited capacity expansions constrained Sevelamer Carbonate availability in Q3 2025.
• Finished goods inventories for chemicals were negative in Q3 2025, indicating reduced stock levels.
• Industrial production saw a slight 0.1% increase in September 2025, reflecting near stagnation in overall output.
• Consumer confidence declined to 94.2 in September 2025, suggesting a weakening economic outlook.
Why did the price of Sevelamer Carbonate change in September 2025 in North America?
• Rising Epichlorohydrin costs and a 2.6% PPI in August 2025 increased production expenses.
• Tight Epichlorohydrin supply and negative finished goods inventories constrained availability.
• Increased drug approvals and a 4.3% unemployment rate supported demand.
APAC
• In China, the Sevelamer Carbonate Price Index fell quarter-over-quarter in Q3 2025, influenced by declining producer prices.
• Sevelamer Carbonate production costs trended downward in Q3 2025, with producer prices falling 2.3% year-over-year in September.
• The Manufacturing Index contracted in September 2025, signaling industrial slowdown and impacting raw material costs.
• Demand for Sevelamer Carbonate was supported by a 6.5% year-over-year increase in industrial production in September 2025.
• China's innovative drug market expanded significantly in 2025, positively influencing Sevelamer Carbonate demand outlook.
• Ample propylene supply and softened upstream crude oil prices contributed to lower Sevelamer Carbonate production costs in Q3 2025.
• Retail sales grew 3.0% year-over-year in September 2025, reflecting healthy consumer spending supporting healthcare.
• Consumer confidence remained pessimistic at 89.6 in September 2025, indirectly impacting healthcare spending.
• Sevelamer Carbonate price forecast suggests continued downward pressure due to persistent global chemical overcapacity in Q3 2025.
Why did the price of Sevelamer Carbonate change in September 2025 in APAC?
• Producer prices fell 2.3% year-over-year in September 2025, reducing Sevelamer Carbonate manufacturing costs.
• The Manufacturing Index contracted in September 2025, indicating weaker industrial demand and lower raw material prices.
• Ample propylene supply and softened crude oil prices in Q3 2025 contributed to overall lower feedstock expenses.
Europe
• In Germany, the Sevelamer Carbonate Price Index fell quarter-over-quarter in Q3 2025, influenced by lower producer prices and subdued industrial demand.
• Production costs saw mixed trends; producer prices fell 1.7% in September 2025 due to lower energy costs.
• However, overall operational expenses increased, as consumer price inflation rose 2.4% in September 2025.
• Demand for Sevelamer Carbonate was supported by moderate pharmaceutical market growth in 2025, driven by an aging population.
• Overall chemical demand was weakened by a subdued industrial economy, with production down 1.0% in September 2025.
• The Manufacturing Index contracted in Q3 2025, reflecting a weaker industrial environment and low capacity utilization.
• Retail sales rose 0.2% in September 2025, indicating stagnant consumer confidence and potential healthcare budget pressure.
• Germany's unemployment rate remained stable at 6.3% in September 2025, potentially straining public finances and healthcare budgets.
Why did the price of Sevelamer Carbonate change in September 2025 in Europe?
• Producer prices fell 1.7% in September 2025, lowering Sevelamer Carbonate production costs.
• Industrial production declined 1.0% in September 2025, indicating weaker overall demand for chemicals.
• Contracting Manufacturing Index in Q3 2025 reflected a subdued industrial economy and low capacity.
